Our future studies will involve determining if DPEP1 expressed on CRC cells can interact with neutrophil and monocytic populations and how DPEP1-positive EVs might enhance this interaction or act as decoys, as we have shown occurs with ACE2-containing EVs in a COVID-19 setting[118]. This evidence concerns the gene DPEP1 and colorectal carcinoma.